| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |
| mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.9 |
| mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |